0001144204-18-042822.txt : 20180808 0001144204-18-042822.hdr.sgml : 20180808 20180808161555 ACCESSION NUMBER: 0001144204-18-042822 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180727 FILED AS OF DATE: 20180808 DATE AS OF CHANGE: 20180808 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Greenleaf Peter CENTRAL INDEX KEY: 0001363683 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36672 FILM NUMBER: 181001538 MAIL ADDRESS: STREET 1: ONE MEDIMMUNE WAY CITY: GAITHERSBURG STATE: MD ZIP: 20878 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EYEGATE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001372514 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 271 WAVERLEY OAKS ROAD STREET 2: SUITE 108 CITY: WALTHAM STATE: MA ZIP: 02452 BUSINESS PHONE: 781-788-9043 MAIL ADDRESS: STREET 1: 271 WAVERLEY OAKS ROAD STREET 2: SUITE 108 CITY: WALTHAM STATE: MA ZIP: 02452 4 1 tv500430_4.xml OWNERSHIP DOCUMENT X0306 4 2018-07-27 0 0001372514 EYEGATE PHARMACEUTICALS INC EYEG 0001363683 Greenleaf Peter C/O EYEGATE PHARMACEUTICALS, INC. 271 WAVERLEY OAKS ROAD, SUITE 108 WALTHAM MA 02452 1 0 0 0 Stock Option (right to buy) 0.57 2018-07-27 4 A 0 50000 0 A 2028-07-27 Common Stock 50000 50000 D The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to 100% of the shares underlying the Option on July 27, 2019. *Signed under power of attorney on behalf of Reporting Person /s/ Robert A. Petitt, Attorney-in-Fact* 2018-08-08